enGene Holdings Inc. (ENGN) vs Lucid Diagnostics Inc. (LUCD)
A side-by-side comparison of enGene Holdings Inc. and Lucid Diagnostics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENGN
enGene Holdings Inc.
$1.81HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
LUCD
Lucid Diagnostics Inc.
$0.61HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — ENGN vs LUCD
growth of $100 · dividends reinvested · last 3yENGN -90.7% (-54.6%/yr)LUCD -54.0% (-22.8%/yr)LUCD compounded faster over this window
ENGN LUCD
ENGN vs LUCD: by the numbers
- •ENGN is the larger company ($121M vs $116M market cap).
- •Both run net losses; ENGN's is the smaller (0.00% vs -959.76% net margin).
Metrics side by side
Valuation
| Metric | ENGN | LUCD |
|---|---|---|
| P/S ratio | N/A | 21.22 |
| P/B ratio | 0.53 | 10.58 |
Profitability
| Metric | ENGN | LUCD |
|---|---|---|
| Gross margin | 0.00% | -60.26% |
| Operating margin | 0.00% | -1054.82% |
| Net margin | 0.00% | -959.76% |
| ROE | -2.13% | -478.26% |
| ROIC | -1.78% | -145.10% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.